Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)

Launched by BIOTRONIK SE & CO. KG · Aug 28, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at how well the BIOTRONIK Implantable Cardiac Monitor (ICM) works for patients with heart conditions like fast heartbeats, irregular heart rhythms, and fainting. Researchers want to understand how safe and effective these devices are over time when used in everyday healthcare settings. The study also allows for additional research opportunities without putting too much extra burden on patients or healthcare providers.

To participate, you need to be 18 years or older and planning to receive a BIOTRONIK ICM. You should also be able to understand the study and give your written consent, as well as be willing to use the CardioMessenger, a device that helps with monitoring your heart at home. If you're pregnant or breastfeeding, or if you're already part of another clinical trial, you won't be eligible for this study. If you join, you'll help researchers gather important information that could improve heart care for everyone.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient is intended to receive a BIOTRONIK Implantable Cardiac Monitor (ICM)
• • Patient is able to understand the nature of the registry and to provide written informed consent.
• • Patient is willing and able to use the CardioMessenger and accepts the BIOTRONIK Home Monitoring concept.
• Exclusion Criteria:
• • Patient is pregnant or breast feeding.
• • Patient is less than 18 years old.
• • Patient is participating in another interventional clinical investigation other than the submodules of BIO\|STREAM.ICM